This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James J. Leyden, MD

Arch Dermatol. 1985;121(7):855-857.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The six articles about infection in immunocompromised hosts in this issue of the ARCHIVES underscore a major challenge in modern medicine. The use of systemic corticosteroids, chemotherapeutic agents, and x-ray therapy have been refined to the point where successful organ transplantation and remission of leukemia and other malignancies are commonplace. Serious infection in these patients remains a major risk of immunosuppressive therapy. In addition to compromise of the immune system induced by therapeutic maneuvers, disease processes, such as malignancy and the acquired immunodeficiency syndrome, render other patients at risk for infection. With the exception of patients with pemphigus and pemphigoid, who are receiving highdose systemic corticosteroid therapy, dermatologists are not usually primary physicians for immunosuppressed patients. Often, however, they are called in for consultation about patients with compromised immune systems. A high index of suspicion for an infectious process should be maintained when a physician examines a patient who is . . . [Full Text PDF of this Article]

Author Affiliations
Dermatology Department University of Pennsylvania Hospital 3400 Spruce St 2 W Gates Bldg Philadelphia, PA 19104

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?